These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28425787)

  • 1. Defining the proteomic landscape of rheumatoid arthritis: progress and prospective clinical applications.
    Lourido L; Blanco FJ; Ruiz-Romero C
    Expert Rev Proteomics; 2017 May; 14(5):431-444. PubMed ID: 28425787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achievements and challenges of proteomics in the study of rheumatoid arthritis.
    Ruiz-Romero C; Blanco FJ
    Curr Top Med Chem; 2013; 13(6):732-42. PubMed ID: 23574522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging aspects of molecular biomarkers for diagnosis, prognosis and treatment response in rheumatoid arthritis.
    Márquez A; Martín J; Carmona FD
    Expert Rev Mol Diagn; 2016 Jun; 16(6):663-75. PubMed ID: 27043155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for rheumatoid arthritis: making it personal.
    Lindstrom TM; Robinson WH
    Scand J Clin Lab Invest Suppl; 2010; 242():79-84. PubMed ID: 20515283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomics, proteomics and metabolomics: their emerging roles in the discovery and validation of rheumatoid arthritis biomarkers.
    Castro-Santos P; Laborde CM; Díaz-Peña R
    Clin Exp Rheumatol; 2015; 33(2):279-86. PubMed ID: 25572119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics and irritable bowel syndrome.
    Tsigaridas A; Papanikolaou IS; Vaiopoulou A; Anagnostopoulos AK; Viazis N; Karamanolis G; Karamanolis DG; Tsangaris GT; Mantzaris GJ; Gazouli M
    Expert Rev Proteomics; 2017 May; 14(5):461-468. PubMed ID: 28395553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities and challenges for the discovery and validation of proteomic biomarkers for common arthritic diseases.
    Ourradi K; Sharif M
    Biomark Med; 2017 Oct; 11(10):877-892. PubMed ID: 28976778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics, transcriptomics and proteomics to elucidate the pathogenesis of rheumatoid arthritis.
    Song X; Lin Q
    Rheumatol Int; 2017 Aug; 37(8):1257-1265. PubMed ID: 28493174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do we improve treatments for patients with amyloidosis using proteomics?
    Lavatelli F; Merlini G
    Expert Rev Proteomics; 2017 Jul; 14(7):561-563. PubMed ID: 28524784
    [No Abstract]   [Full Text] [Related]  

  • 10. Antigen microarray profiling of autoantibodies in rheumatoid arthritis.
    Hueber W; Kidd BA; Tomooka BH; Lee BJ; Bruce B; Fries JF; Sønderstrup G; Monach P; Drijfhout JW; van Venrooij WJ; Utz PJ; Genovese MC; Robinson WH
    Arthritis Rheum; 2005 Sep; 52(9):2645-55. PubMed ID: 16142722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics Approach for the Discovery of Rheumatoid Arthritis Biomarkers Using Mass Spectrometry.
    Mun S; Lee J; Park A; Kim HJ; Lee YJ; Son H; Shin M; Lim MK; Kang HG
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel urinary biomarkers for assessing disease activity and prognosis of rheumatoid arthritis.
    Park YJ; Yoo SA; Hwang D; Cho CS; Kim WU
    Exp Mol Med; 2016 Feb; 48(2):e211. PubMed ID: 26915672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated proteomic and glycoproteomic study for differences on glycosylation occupancy in rheumatoid arthritis.
    Li X; Ding L; Li X; Zhu H; Gashash EA; Li Z; Wang PG; Ma C
    Anal Bioanal Chem; 2019 Mar; 411(7):1331-1338. PubMed ID: 30729266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein profiling and network enrichment analysis in individuals before and after the onset of rheumatoid arthritis.
    Brink M; Lundquist A; Alexeyenko A; Lejon K; Rantapää-Dahlqvist S
    Arthritis Res Ther; 2019 Dec; 21(1):288. PubMed ID: 31842970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics Analysis for Verification of Rheumatoid Arthritis Biomarker Candidates Using Multiple Reaction Monitoring.
    Lee J; Mun S; Kim D; Lee YR; Sheen DH; Ihm C; Lee SH; Kang HG
    Proteomics Clin Appl; 2019 May; 13(3):e1800011. PubMed ID: 30230224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics: applications to the study of rheumatoid arthritis and osteoarthritis.
    Gobezie R; Millett PJ; Sarracino DS; Evans C; Thornhill TS
    J Am Acad Orthop Surg; 2006 Jun; 14(6):325-32. PubMed ID: 16757672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a decision tree model for diagnosis of early rheumatoid arthritis by proteomic fingerprinting.
    Li Y; Sun X; Zhang X; Liu Y; Yang Y; Li R; Liu X; Jia R; Li Z
    Int J Rheum Dis; 2015 Nov; 18(8):835-41. PubMed ID: 26249836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics in cardiovascular disease: recent progress and clinical implication and implementation.
    Mokou M; Lygirou V; Vlahou A; Mischak H
    Expert Rev Proteomics; 2017 Feb; 14(2):117-136. PubMed ID: 27997814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: an exploratory analysis.
    Ortea I; Roschitzki B; Ovalles JG; Longo JL; de la Torre I; González I; Gómez-Reino JJ; González A
    J Proteomics; 2012 Dec; 77():372-82. PubMed ID: 23000593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Novel Diagnostic Biomarker Set for Rheumatoid Arthritis Using a Proteomics Approach.
    Mun S; Lee J; Lim MK; Lee YR; Ihm C; Lee SH; Kang HG
    Biomed Res Int; 2018; 2018():7490723. PubMed ID: 30662913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.